Ontology highlight
ABSTRACT: Background
Whether autologous hematopoietic stem cell transplantation (ASCT) improves the survival of patients with peripheral T-cell lymphoma (PTCL) remains controversial. Some studies have demonstrated that the efficacy of ASCT is superior in patients with complete remission (CR), whereas patients with partial remission (PR) remain vulnerable to relapse after ASCT, resulting in decreased survival rates. Maintenance therapy after chemotherapy may reduce the relapse rate of PTCL and improve survival; however, the role of maintenance therapy after ASCT in PTCL remains unclear. In this study, we aimed to analyze the efficacy of ASCT and post-transplant maintenance therapy in PTCL. Methods
We retrospectively analyzed the clinical data of 69 patients with PTCL who underwent A
SUBMITTER: Huang Z
PROVIDER: S-EPMC10225554 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature